Items tagged with Diagnostics
WHO announces updates to its guidelines on tests for the diagnosis of TB infection (post with simple image)
The World Health Organization releases updated guidelines and a new operational handbook on tests for the diagnosis of TB infection.
TAG's 2022 Pipeline Report: TB Diagnostics (post with simple image)
Treatment Action Group launches the 2022 Tuberculosis Diagnostics Pipeline Report.
New manual on IGRA tests for TB infection launched (post with simple image)
The manual provides an overview of the recommended use of IGRAs as a class of in-vitro tests for the detection of TB infection and describes their performance, steps for use and implementation considerations.
Urgent action necessary to improve equitable access to GeneXpert TB diagnostics and achieve 1/4/6x24 (post with simple image)
Advocates urge Cepheid to take immediate action necessary to bring about affordable, equitable, and expanded access to GeneXpert TB testing.
TAG applauds price reduction of Molbio’s Truenat diagnostics for TB (post with simple image)
TAG applauds Molbio’s agreement with the Stop TB Partnership, USAID, and the Global Fund to reduce the price of Truenat diagnostics for TB from US$9 per test to $7.90 per test and to provide quality service and maintenance of Truenat testing instruments globally.
WHO releases first-ever Standard on universal access to rapid TB diagnostics (post with simple image)
The Standard sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics, increase bacteriologically confirmed TB and drug resistance detection, and reduce the time to diagnosis.
Reduced price and increased access to Cepheid’s TB test (post with simple image)
Global Fund, Stop TB Partnership and USAID announce new collaboration with Danaher to reduce price and increase access to Cepheid’s TB test. Five million additional tests can be procured with this lower price.
Target Regimen Profiles for TB treatment and Target Product Profiles for TB tests (post with simple image)
The World Health Organization releases updated Target Regimen Profiles for TB treatment and new Target Product Profiles for tests for TB treatment monitoring and optimization.
TAG's 2023 Pipeline Report: TB Diagnostics (post with simple image)
Treatment Action Group launches the 2023 Tuberculosis Diagnostics Pipeline Report.
Technical brief: Access to TB testing and treatments: GeneXpert and delamanid (post with simple image)
Médecins Sans Frontières issues a report offering case studies of two critical TB tools, GeneXpert and delamanid, and outlining actions that the corporations making them need to take to unlock access to these tools.
Page 65 of 66 · Total posts: 0←First 64 65 66 Last→